Skip to content

Logan's Continuous Glucose Monitor

Logan's continuous glucose monitor was the device that tracked his blood sugar every five minutes, day and night, from the time he was eleven years old until the end of his life. What began as a clinical tool prescribed at diagnosis became something more layered--a mediator of independence, a source of tension between Logan's need for control and his body's refusal to be controlled, and a quiet witness to every crash, spike, and moment of neglect his perfectionism inflicted on himself.

Overview

Logan Weston was diagnosed with Type 1 Diabetes in 2019, at age eleven, after nearly a year of Julia Weston's persistent advocacy against doctors who dismissed her concerns. The continuous glucose monitor was prescribed as part of his initial diabetes management setup alongside insulin therapy. Logan's first CGM was a Dexcom G6, the standard of care at the time, which he wore continuously from diagnosis through mid-adolescence. When Dexcom released the G7 in 2023, Logan upgraded at fifteen--the smaller, all-in-one sensor with its thirty-minute warmup replacing the bulkier two-piece G6 he'd worn for four years.

The CGM operated as part of a closed-loop system with Logan's insulin pump, meaning the two devices communicated continuously--the CGM feeding real-time glucose data to the pump, which auto-adjusted basal insulin delivery in response. Logan could also pre-bolus manually when he anticipated a blood sugar rise, as he did before meals out or occasions where he knew he'd be eating something that would spike his numbers. The system was sophisticated, responsive, and--when Logan actually listened to it--effective.

What It Monitors

The Dexcom measured Logan's interstitial glucose levels every five minutes through a tiny sensor filament inserted just beneath the skin. The data streamed to his iPhone's Dexcom app and his Apple Watch, displaying his current glucose number, a trend arrow showing which direction his blood sugar was heading, and a graph of the last several hours of readings. The system generated predictive alerts--warnings that his glucose was dropping or rising toward dangerous thresholds--giving him time to intervene before a crisis.

The closed-loop integration with his insulin pump meant that in routine situations, the system managed itself. Basal rates adjusted automatically based on glucose trends, suspending delivery when readings dropped too low and increasing it when they climbed. But the system couldn't account for everything--stress, illness, adrenaline, skipped meals, the particular chaos of a seventeen-year-old pushing himself past every reasonable limit. Those variables required human judgment, and Logan's judgment about his own body was, for years, catastrophically poor.

The Physical Experience

By the time Logan had worn a CGM for two or three years, it had faded almost entirely into the background of his physical awareness. The sensor sat on the back of his upper arm--a small adhesive patch with a slight bump where the transmitter housing lived. He rotated sites regularly to prevent skin irritation, alternating arms and occasionally using his upper thigh, though after his spinal cord injury in late 2025, he permanently avoided his abdomen due to reduced sensation below the injury level.

The adhesive sometimes itched during the last day of a sensor's ten-day wear cycle, and humid Baltimore summers could loosen the edges, requiring overtape to keep the sensor in place. The insertion of a new sensor involved a brief, sharp pinch from the auto-applicator--a sensation Logan had stopped flinching at by age twelve. The G7's smaller footprint made it less noticeable under clothing than the G6 had been, though it was still visible in short sleeves--a small oval patch that read as medical device to anyone who knew what they were looking at.

Logan didn't think about the sensor most of the time. It was simply part of his body, the way his watch or his glasses would be for someone else--present, functional, unremarkable. The moments it reasserted itself were the alerts: the vibration on his wrist from the Apple Watch, the urgent tone from his phone when his glucose crossed a threshold. Those sounds were the CGM's voice, and Logan's relationship with that voice was complicated.

Data, Sharing, and Who's Watching

The Dexcom Follow app created an ecosystem of surveillance and care that evolved across Logan's life. During adolescence, both Julia and Nathan had access to Logan's real-time glucose data through the Follow app on their phones. Julia, a neurologist who understood the clinical implications of every trend line, was the primary interpreter--she could glance at Logan's graph and know whether he'd eaten, whether he was stressed, whether he'd been running high for hours. Nathan relied on Julia's expertise, asking her questions when something looked off rather than interpreting the data himself. The arrangement worked because Logan trusted Julia's medical judgment even when he resented the monitoring.

When Logan left for Howard University in the fall of 2025, Julia insisted on maintaining Follow access for his first year. He was seventeen, living away from home for the first time, and she knew her son well enough to know he would deprioritize his diabetes management under academic pressure. She was right. During his first semester, Julia watched Logan's glucose readings become increasingly erratic--the spikes from stress, the lows from skipped meals, the patterns that told her he was pushing too hard long before the finals week collapse confirmed it.

After the December 2025 accident and Logan's recovery, the data-sharing dynamics shifted. Julia and Nathan gradually stepped back from active monitoring as Logan rebuilt his independence in his twenties. Charlie Rivera became the person who watched. Charlie's access to Logan's Dexcom data was a quiet constant in their relationship--he could see the numbers on his own phone, could know without asking whether Logan had eaten, whether his blood sugar was stable, whether the man who refused to admit he was struggling was, in fact, struggling. For Logan, who built his identity on self-sufficiency, Charlie's access represented both comfort and vulnerability. He never asked Charlie to stop watching. He also never fully made peace with being watched.

The tension surfaced most when Logan was pushing himself--long hours at the clinic, nights spent on research when he should have been sleeping, the relentless drive that defined him. Charlie could see the glucose chaos that overwork produced, and Logan knew Charlie could see it. The CGM data became a proxy for the conversations they had over and over: Logan insisting he was fine, Charlie's phone telling a different story.

Alerts and Responses

The Dexcom's alert system was configured with standard thresholds--urgent low at 55 mg/dL, low at 70, high at 250--and Logan generally left these at their defaults. The alerts manifested as vibrations on his Apple Watch and audible tones on his iPhone, escalating in urgency as glucose levels moved further from range.

Logan's relationship with the alerts was the clearest window into his psychology. He was not a person who ignored information out of ignorance or carelessness. He was a person who, when the information conflicted with what he was trying to accomplish, chose accomplishment. The pattern established itself in high school and never fully resolved.

The most documented incident was the CCBC presentation collapse during senior year. Logan's Dexcom alarmed throughout his presentation on neuroplasticity in adolescent brain development at CCBC Essex, warning him that his glucose was dropping toward 54 mg/dL. He muted the alarm without checking the reading and kept presenting. Thirty-two slides of immaculate research, thirty percent of his final grade for Professor Harrington's course. The Dexcom did its job--alerting with increasing urgency, vibrating URGENT LOW GLUCOSE in red text. Logan refused to listen. He collapsed at the podium, the brilliant performance ending not with a conclusion but with darkness rushing up to meet him. The Dexcom had been right every time. Logan had overruled it every time.

This was not an isolated incident. The "Weston Double"--spectacular performance followed by physical collapse--became Logan's signature pattern through high school and into Howard. During his finals week breakdown in December 2025, his Dexcom readings were "increasingly erratic" as stress, sleep deprivation, and emotional crisis wreaked havoc on his blood sugar management. The CGM recorded every spike and crash with clinical precision. Logan recorded none of it as a reason to stop.

Daily Routine

Logan's diabetes management was, in practical terms, meticulous. He checked his Dexcom app regularly throughout the day--a quick glance at his Apple Watch between patients, a longer look at the trend graph on his phone during breaks. He pre-bolused before meals when he knew what he was eating, calculating carb counts with the automatic precision of someone who'd been doing it since childhood. Sensor changes happened every ten days, a brief routine he could complete in under two minutes--clean the site, apply the new sensor, wait for the thirty-minute warmup, calibrate if needed.

The discipline was genuine. Logan understood his diabetes with clinical sophistication that went beyond patient knowledge into physician-level comprehension. He knew the pharmacokinetics of his insulin, the glycemic impact of specific foods, the way stress hormones and sleep deprivation affected his glucose metabolism. He was, by any objective measure, excellent at managing his diabetes.

The problem was never knowledge or routine. The problem was that Logan's hierarchy of priorities placed achievement above his body's needs, and when the two conflicted, achievement won. He would manage his diabetes perfectly for weeks and then blow through every alarm during a high-stakes presentation because stopping to eat glucose tabs in front of an audience felt like weakness. The CGM couldn't fix that. It could only document it.

The CGM and the Body

Logan's relationship with the CGM tracked the broader evolution of his relationship with his body. Before the accident, the CGM was one piece of a manageable chronic condition--annoying, sometimes inconvenient, but fundamentally a solved problem. He knew how to manage Type 1. He was good at it. The CGM was a tool that made management easier, and he used it with the same efficiency he applied to everything.

After the spinal cord injury, everything changed. The CGM became critical safety equipment. With reduced sensation below his thoracic/lumbar injury, Logan could no longer rely on his body's natural hypoglycemia warning signs--the sweating, the shakiness, the gut feeling that something was dropping. Those autonomic responses were altered by the SCI. The Dexcom's predictive alerts became his primary warning system, the difference between catching a low early and crashing without warning. The sensor site limitations changed too--his abdomen, a common placement site, was no longer viable due to reduced sensation and potentially altered blood flow. The back of the upper arm became his default, with occasional rotation to his thigh.

The accident also changed who monitored the data. During his eighteen-day coma and the weeks of acute care that followed, Logan's personal Dexcom was not in use--hospital staff managed his glucose with IV insulin and their own monitoring equipment. Getting back on his own CGM was part of the transition out of intensive care, a small but significant marker of reclaiming autonomy over his body. Julia oversaw the transition with the precision of someone who understood both the medicine and her son's psychology--knowing that returning Logan's diabetes management to his own hands was essential for his recovery, even as she kept her Follow app open on her phone.

Social Visibility

As an adolescent, the CGM was part of why Logan preferred continuous monitoring over finger sticks. The sensor lived under his sleeve, invisible to classmates. A quick glance at his phone to check his glucose was indistinguishable from checking a text message. The lancet, the test strips, the blood on his fingertip--that was visible, conspicuous, medical. The CGM let him manage his diabetes without announcing it.

For a Black teenager navigating Edgewood High School--already standing out as one of the smartest kids in the room, already fielding "try-hard" comments from classmates--the CGM's invisibility mattered. It was one less thing that marked him as different, one less thing that invited questions or assumptions or pity. Logan didn't hide his diabetes, but he didn't advertise it either, and the CGM let him manage that boundary on his own terms.

In adulthood, as a physician and public figure in the disability community, Logan's relationship with the CGM's visibility shifted. The sensor patch on his arm was simply part of who he was--visible in short sleeves, occasionally noticed by patients who recognized it, unremarkable to him. He'd long since stopped caring whether people saw it.

When It Fails

The Dexcom G6 and Logan's insulin pump were both damaged in the December 12, 2025 car accident--the impact that broke his body also broke the devices that managed it. During the coma and acute recovery, hospital systems took over, but the destruction of his personal equipment in the crash underscored a vulnerability that continuous monitoring usually masked: without the CGM, Logan's diabetes became someone else's problem to manage, and Logan was unconscious to have any say in it.

Sensor failures, signal loss, and adhesive failures were routine irritations across years of wear. A sensor that read inaccurately could be replaced; a transmitter that lost Bluetooth connection to his phone would reconnect. These minor failures were logistical problems, not crises. The real failures were human--the alerts Logan silenced, the trends he ignored, the data he had and chose not to act on because something else mattered more in the moment.

The Emotional Relationship

By thirteen, Logan had made his peace with the CGM. It was not a thing he resented or celebrated. It was simply part of the infrastructure of being Logan Weston--like brushing his teeth, like taking insulin, like the particular way his body required management that other people's bodies did not. He wished, sometimes, that he could eat whatever he wanted without calculating the cost. He wished he didn't have to think about it. But the wishing was brief and pragmatic--it wouldn't change anything, so he didn't dwell.

What Logan never fully resolved was the tension between the CGM as a tool of independence and the CGM as evidence of vulnerability. The device that freed him from finger sticks also broadcast his body's data to the people who loved him. The device that caught dangerous lows also recorded every time he pushed too hard. The device that auto-adjusted his insulin also proved, in its data logs, that his body couldn't be trusted to regulate itself. For a man whose identity was built on competence, self-sufficiency, and control, wearing a device that quantified his body's failures was a quiet, permanent negotiation.

He never took it off. He never wanted to. But he also never stopped being aware that it knew things about him that he'd rather handle alone.

Technology Wearable Technology Health Monitoring Logan Weston Type 1 Diabetes